| 查看: 372 | 回复: 20 | |||
| 当前主题已经存档。 | |||
| 【悬赏金币】回答本帖问题，作者chendiqing将赠送您 30 个金币 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
chendiqing铁杆木虫 (知名作家)
|
[求助]
查文献的题目，一个5金币，难找的一个10~20金币啊【已解决，谢谢大家】
|
||
|
各位兄弟姐妹们，帮忙查一下以下文献的题目啊，就只它文献的题目就可以了，找到一个5金币，难找的一个10~20金币不等，拜托了啊~~~~ 1，Biginelli , P. Gazz. Chim. Ital . 1893 , 23 , 360. 2，Kappe , C. O. Tetrahedron 1993 , 49 , 6937. 3，Grover , G. J . ; Dzwonczyk , S. ; McMullen , D. M. ; Grover ,C. S. ; Sleph , P. G. ; Moreland , S. J . J . Cardiovasc. Pharmacol . 1995 , 26 , 289. 4，Atwal , K. S. ; Swanson , B. N. ; Unger , S. E. ; Floyd , D. M. ; Moreland , S. ; Hedberg , A. ; O′eilly , B. C. J . Med. Chem. 1991 , 34 , 806. 5，Rovnyak , G. C. ; Atwal , K. S. ; Hedberg , A. ; Kim2 ball , S. D. ; Moreland , S. ; Gougoutas , J . Z. ; O’eil2ly , B. C. ; Schwartz , J . ; Malley , M. F. J . Med.Chem. 1992 , 35 , 3254. 6，Nagarathnam , D. ; Miao , S. W. ; Lagu , B. ; Chiu , G. ; Fang , J . ; MDhar , T. G. ; Zhang , J . ; Tyagarajan , S. ; Marzabadi , M. R. ; Zhang , F. Q. ; Wong , W. C. ; Sun , W. Y. ; Tian , D. ; Wetzel , J . M. ; Forray , C. ; Chang , R. S. L. ;Broten , T. P. ; Ransom , R. W. ;Schorn , T. W. ; Chen , T. B. ; O′Malley , S. ;Kling , P. ; Schneck , K. ; Benedesky , R. ; Harrell , C. M. ; Vyas , K. P. ;Gluchowski , C. J . Med. Chem. 1999 , 42 , 4764. 7，Barrow , J . C. ; Nantermet , P. G. ; Selnick , H. G. ; Glass , K. L. ; Rittle , K. E. ; Gilbert , K. F. ; Steele , T. G. ; Homnick , C. F. ; Freidinger , R. M. ; Ransom , R. W. ; Kling , P. ; Reiss , D. ; Broten , T. P. ; Schorn , T. W. ; Chang , R. S. L. ; O′Malley , S. S. ; Olah , T. V. ; Ellis , J . D. ; Barrish , A. ; Kassahun , K. ; Leppert , P. ; Nagarathnam , D. ; Forray , C. J . Med. Chem. 2000 , 43 , 2703. 8，Ma , Y. ; Qian , C. ; Wang , L. ; Yang , M. J . Org. Chem. 2000 , 65 , 3864. 9，Ranu , B. C. ; Hajra , A. ; Jana , U. J . Org. Chem. 2000 , 65 , 6270. 10，Wipf , P. ; Cunningham , A. Tetrahedron Lett . 1995 , 36 ,7819. 11，Studer , A. ; Jeger , P. ; Wipf , P. ; Curran , D. P. J . Org.Chem. 1997 , 62 , 2917. [ Last edited by zzgyb on 2008-7-17 at 10:57 ] |
回复此楼» 猜你喜欢
招博士
已经有6人回复
-
限项规定
已经有8人回复
-
国家基金申请书模板内插入图片不可调整大小?
已经有5人回复
-
交叉科学部支持青年基金，对三无青椒是个机会吗？
已经有3人回复
-
国家级人才课题组招收2026年入学博士
已经有5人回复
-
Fe3O4@SiO2合成
已经有6人回复
-
青年基金C终止
已经有4人回复
-
青椒八年已不青，大家都被折磨成啥样了？
已经有7人回复
-
为什么nbs上溴 没有产物点出现呢
已经有10人回复
-
救命帖
已经有11人回复
|
详细的4：hydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents.Atwal KS, Swanson BN, Unger SE, Floyd DM, Moreland S, Hedberg A, O'Reilly BC. Squibb Institute for Medical Research, Princeton, New Jersey 08543-4000. In order to explain the potent antihypertensive activity of the modestly active (IC50 = 3.2 microM) dihydropyrimidine calcium channel blocker 5, we carried out drug metabolism studies in the rat and found 5 is metabolized to compounds 6-10. Two of the metabolites, 6 (IC50 = 16 nM) and 7 (IC50 = 12 nM), were found to be responsible for the antihypertensive activity of compound 5. Potential metabolism of 6 into 7 in vivo precluded our interest in pursuing compounds related to 6. Structure-activity studies aimed at identifying additional aryl-substituted analogues of 7 led to 17g,j,p with comparable potential in vivo, though these compounds were less potent than 7 in vitro. To investigate the effects of absolute stereochemistry on potency, we resolved 7 via diastereomeric ureas 19a,b, prepared from 18 by treatment with (R)-alpha-methylbenzylamine. Our results demonstrate that the active R-(-)-enantiomer 20a of 7 is both more potent and longer acting than nifedipine (1) as an antihypertensive agent in the SHR. The in vivo potency and duration of 20a is comparable to the long-acting dihydropyridine amlodipine. The superior oral antihypertensive activity of 20a compared to that of previously described carbamates 2 (R2 = COOEt) could be explained by its improved oral bioavailability, possibly resulting from increased stability of the urea functionality. PMID: 1995904 [PubMed - indexed for MEDLINE] |
17楼2008-06-16 22:50:18
2楼2008-06-16 22:09:27
3楼2008-06-16 22:13:01
★ ★ ★ ★ ★
chendiqing(金币+5,VIP+0):哇哦，谢谢哥们你啊~~~~
chendiqing(金币+5,VIP+0):哇哦，谢谢哥们你啊~~~~
|
3.Titre du document / Document title Pharmacologic profile of the dihydropyrimidine calcium channel blockers SQ 32,547 and SQ 32,946 Auteur(s) / Author(s) GROVER G. J. ; DZWONCZYK S. ; MCMULLEN D. M. ; NORMANDIN D. E. ; PARHAM C. S. ; SLEPH P. G. ; MORELAND S. ; Affiliation(s) du ou des auteurs / Author(s) Affiliation(s) Bristol-Myers Squibb pharmaceutical res. inst., dep. pharmacology, Princeton NJ 08543, ETATS-UNIS Résumé / Abstract SQ 32,926 and SQ 32,547, two dihydropyrimidine calcium channel blockers, were characterized as potent inhibitors of depolarization-induced contractions of isolated smooth muscle preparations. In rat aorta, the IC50 values were 5.5 nM for SQ 32,547 and 8.1 nM for SQ 32,926, values which compare favorably with that of 2.9 nM for nifedipine. The dihydropyrimidines were also tested in a model of stable angina : pacing-induced ischemia in dogs. Both SQ 32,547 and SQ 32,926 reduced the ST-segment elevation observed in vehicle-treated animals. No significant changes in hemodynamic status were detected, suggesting that a reduction in cardiac work secondary to afterload reduction was probably not a major contributor to the protective effects. Neither was increased coronary blood flow important for the antiischemic outcome because no significant effects of the dihydropyrimidines were observed on ischemic regional blood flow. SQ 32,547 was also studied in globally ischemic, isolated rat hearts. In this model, SQ 32,547 was protective because it significantly reduced contracture formation and lactate dehydrogenase (LDH) release. Washing out the effect of SQ 32,547 in isolated hearts and smooth muscles was difficult, presumably due to its lipophilicity. In the smooth muscle preparations, the effects of both nifedipine and SQ 32,926 were much more easily washed out. As with other calcium channel blockers, increasing the antiischemic effects of SQ 32,547 was associated with a higher cost in terms of cardiac function. In summary, the two novel dihydropyrimidines, SQ 32,547 and SQ 32,926, showed antiischemic properties in animal models. Revue / Journal Title Journal of cardiovascular pharmacology ISSN 0160-2446 CODEN JCPCDT Source / Source 1995, vol. 26, no2, pp. 289-294 (24 ref.) Langue / Language Anglais Editeur / Publisher Lippincott, Hagerstown, MD, ETATS-UNIS (1979) (Revue) Mots-clés anglais / English Keywords Calcium antagonist ; Antiïschemic ; Angina pectoris ; Chemotherapy ; Treatment ; Smooth muscle ; Heart ; Rat ; Animal ; In vivo ; In vitro ; Rodentia ; Mammalia ; Vertebrata ; Cardiovascular disease ; Coronary heart disease ; Mots-clés français / French Keywords Antagoniste calcium ; Antiischémique ; Angine poitrine ; Chimiothérapie ; Traitement ; Muscle lisse ; Coeur ; Rat ; Animal ; In vivo ; In vitro ; SQ 32 547 ; SQ 32 946 ; Dihydropyrimidine dérivé ; Cardioprotecteur ; Rodentia ; Mammalia ; Vertebrata ; Appareil circulatoire pathologie ; Cardiopathie coronaire ; Mots-clés espagnols / Spanish Keywords Antagonista calcio ; Antiisquémico ; Angina pectoris ; Quimioterapia ; Tratamiento ; Músculo liso ; Corazón ; Rata ; Animal ; In vivo ; In vitro ; Rodentia ; Mammalia ; Vertebrata ; Aparato circulatorio patología ; Cardiopatía coronaria ; Localisation / Location INIST-CNRS, Cote INIST : 18065, 35400005361515.0140 |
4楼2008-06-16 22:15:46